This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Mitsubishi Tanabe Pharma Corporation. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yoshiari Yanai and His Patent for ME/CFS and Fibromyalgia Treatment.
Introduction
Yoshiari Yanai is an inventor associated with Osaka, Japan, and Mitsubishi Tanabe Pharma Corporation. His work includes a patent concerning a potential therapeutic agent for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and fibromyalgia.
Latest Patents
Yanai is listed as an inventor on 1 patent, titled “Therapeutic agent for myalgic encephalomyelitis/chronic fatigue syndrome.” The invention describes a therapeutic agent for ME/CFS or fibromyalgia containing 2-amino-2-[2-(4-heptyloxy-3-trifluoromethylphenyl)ethyl]propane-1,3-diol, or a pharmaceutically acceptable salt of that compound. The patent’s stated aim is to provide a treatment option for these conditions.
Career Highlights
Yanai’s patent work is associated with Mitsubishi Tanabe Pharma Corporation, a pharmaceutical company. The patent reflects research directed toward developing therapeutic approaches for ME/CFS and fibromyalgia.
Collaborations
Hitoshi Izaki and Rikako Hayashi are identified as Yanai’s coworkers. The provided information does not specify their roles in the patent or the nature of their collaboration.
Conclusion
Yoshiari Yanai’s recorded patent activity includes an invention proposing a therapeutic agent for ME/CFS and fibromyalgia, developed in connection with Mitsubishi Tanabe Pharma Corporation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile